Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB
Bayesian Borrowing for Fracture Risk Factors in Female Romosozumab New Users Across Racial and Ethnic Subgroups (ACR Convergence 2026) - Sep 8, 2026 - Abstract #0620; Pres time: Nov 8, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; "Bayesian borrowing from the largest subgroup (White women) improved estimation of fracture risk factors and identified associations within racial/ethnic subgroups that were not detected in subgroup-specific frequentist models. The Bayesian approach may help reveal subgroup-specific risk patterns and increase clinicians' awareness of different risk factors in racial and ethnic subgroups that have fewer romo users." 
Clinical • Musculoskeletal Diseases • Orthopedics • Rare Diseases
https://acrabstracts.org/abstract/bayesian-borrowing-for-fracture-risk-factors-in-female-romosozumab-new-users-across-racial-and-ethnic-subgroups/
 
Hongke Wu1; Ye Liu1; Tarun Arora2; Jeffrey Curtis3
 
Sep 8, 2026
 
Prev Next